K Number
K214005
Date Cleared
2022-02-18

(59 days)

Product Code
Regulation Number
872.6660
Panel
Dental
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Zirconia Dental Ceramics are intended for dental restorations using different CAD/CAM or manual milling machines. All blocks are processed through dental laboratories or by dental professionals.

Device Description

Zirconia Dental Ceramics is composed of yttria-stabilized zirconia. It contains ZrQz+HfO2+Y2O3 and additional Al2O3 and other oxides. It offers various shapes and dimensions suitable for different milling systems. The performance of the proposed device conforms to ISO 6872:2015 Dentistry: Ceramic Materials.

The proposed device is processed into the dental restorations such as crowns, bridges, veneers, inlays and onlays based on the anatomical rendering of the patient's teeth using CAD/CAM (computer aided design / computer aided manufacturing) method or manual milling method.

The proposed device is a single-use device, and provided non-sterile.

AI/ML Overview

This document describes the premarket notification (510(k)) for "Zirconia Dental Ceramics." The primary purpose of this document is to demonstrate "substantial equivalence" to a legally marketed predicate device, rather than to prove clinical performance or a specific diagnostic accuracy. Therefore, the questions related to AI/ML device performance (e.g., acceptance criteria for accuracy, MRMC studies, ground truth establishment for training/test sets, expert adjudication) are largely not applicable to this type of medical device submission (dental ceramics).

The acceptance criteria and "study" described in this document are focused on non-clinical performance testing to demonstrate that the physical, chemical, and biological properties of the Zirconia Dental Ceramics conform to established standards for dental ceramic materials.

Here's an analysis based on the provided text, addressing the points where information is available and indicating where it's not applicable:


Acceptance Criteria and Device Performance for Zirconia Dental Ceramics

The acceptance criteria for this device are based on demonstrating compliance with the international standard ISO 6872:2015 "Dentistry - Ceramic materials" and ISO 7405:2018 "Dentistry - Evaluation of biocompatibility of medical devices used in dentistry" for biocompatibility.

1. Table of Acceptance Criteria and Reported Device Performance

Test ItemAcceptance Criteria (ISO 6872:2015, etc.)Reported Device Performance (Zirconia Dental Ceramics)Judgment
UniformityUniform (Expected for ceramic materials)UniformPass
Freedom from extraneous materialsFree from extraneous materials (Expected)Free from extraneous materialsPass
Radioactivity≤ 1.0 Bq.g⁻¹<0.017 Bq.g⁻¹Pass
Flexural strength≥ 800 MPa1076.4 MPaPass
Linear thermal expansion coefficient(10.5 ± 0.5) × 10⁻⁶ K⁻¹ (as per predicate/reference)10.7 × 10⁻⁶ K⁻¹Pass
Chemical solubility< 100 µg/cm²54.2 µg/cm²Pass
Shrinkage factor1.253 ± 0.002 (as per reference device value)1.254Pass
Fracture Toughness≥ 5.0 MPa·m¹/²16.32 MPa·m¹/²Pass
Biocompatibility TestingAcceptance Criteria (ISO 7405:2018, ISO 10993 series)Reported Test Results
Cytotoxicity (ISO 10993-5:2009, 6.2/6.3 of ISO 7405:2018)No cytotoxicityNo cytotoxicity under the conditions of the studyPass
Skin Sensitization (ISO 10993-10:2010)No skin sensitizationNo skin sensitization under the conditions of the studyPass
Oral Mucosa Irritation (ISO 10993-10:2010)No oral mucosa irritationNo oral mucosa irritation under the conditions of the studyPass
Acute Systemic Toxicity (ISO 10993-11:2017)No acute systemic toxicityNo acute systemic toxicity under the conditions of the studyPass
Subchronic Systemic Toxicity (ISO 10993-11:2017)No subchronic systemic toxicityNo subchronic systemic toxicity under the conditions of the studyPass
Genotoxicity (ISO 10993-3:2014)No genotoxicityNo genotoxicity under the conditions of the studyPass
Implantation (ISO 10993-6:2016)No local effectsNo local effects under the conditions of the studyPass

2. Sample Size Used for the Test Set and Data Provenance

  • Sample Size: The document does not specify the exact sample sizes (e.g., number of test pieces for flexural strength, number of animals for biocompatibility tests). It relies on the methods outlined in the referenced ISO standards.
  • Data Provenance: The tests were conducted to demonstrate conformity with international standards (ISO). The location of the testing laboratories or the origin of the data (e.g., country) is not explicitly stated, but the applicant and consultant are based in Shenzhen, China. The data is retrospective in the sense that it was collected prior to this submission for regulatory review.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of those Experts

  • Not Applicable. This is a material science and biocompatibility study, not an AI/ML diagnostic study. The "ground truth" is defined by the physical/chemical/biological properties and the standards they are measured against, not by human expert interpretation of images or clinical outcomes in the context of diagnostic algorithms. The "experts" are the scientists and technicians performing the standardized tests.

4. Adjudication Method for the Test Set

  • Not Applicable. There is no human interpretation or subjective assessment that requires adjudication in these physical, chemical, and biological tests. The results are quantitative measurements or qualitative observations (e.g., presence/absence of cytotoxicity) based on standardized protocols.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done

  • No. This is not an AI/ML diagnostic device, so MRMC studies are not relevant.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

  • Not Applicable. This is not an algorithm or software device. Performance is measured against material specifications.

7. The Type of Ground Truth Used

  • The "ground truth" for this device is defined by:
    • International Standards: Primarily ISO 6872:2015 for physical/chemical properties and ISO 7405:2018 (and related ISO 10993 series) for biocompatibility.
    • Material Science Principles: The inherent properties of the zirconia material.
    • Laboratory Measurements: Quantitative and qualitative results from standardized test methods.

8. The Sample Size for the Training Set

  • Not Applicable. This device does not involve machine learning; therefore, there is no "training set."

9. How the Ground Truth for the Training Set Was Established

  • Not Applicable. As there is no training set.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

February 18, 2022

Shenzhen Yurucheng Dental Materials Co., Ltd. % Grace Liu Consultant Shenzhen Joyantech Consulting Co. Ltd 1713A, 17th Floor, Block A, Zhongguan Times Square, Nanshan District Shenzhen, Guangdong 518000 China

Re: K214005

Trade/Device Name: Zirconia Dental Ceramics Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder For Clinical Use Regulatory Class: Class II Product Code: EIH Dated: December 12, 2021 Received: December 21, 2021

Dear Grace Liu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic. Anesthesia. Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K214005

Device Name Zirconia Dental Ceramics

Indications for Use (Describe)

Zirconia Dental Ceramics are intended for dental restorations using different CAD/CAM or manual milling machines. All blocks are processed through dental laboratories or by dental professionals.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary - K214005

1. Contact Details

1.1 Applicant information

Applicant NameShenzhen Yurucheng Dental Materials Co., Ltd.
Address101-201, Building 4, No.1 Branch of Zhongcheng LifeScience Park, No. 14 Zhongxing Road, Xiuxin Community,Kengzi Street Office, Pingshan District, Shenzhen, China
Contact personFiya Liao
Phone No.+86-17727849963
E-mailppk-jidcvcvmr@dingtalk.com
Date Prepared2022-02-17

1.2 Submission Correspondent

Image: LogoShenzhen Joyantech Consulting Co., Ltd
1713A, 17th Floor, Block A, Zhongguan Times Square,
Nanshan District, Shenzhen, Guangdong Province, China
Phone No.+86-755-86069197
Contact personGrace Liu; Field Fu;
Contact person's e-mailgrace@cefda.com; field@cefda.com
Websitehttp://www.cefda.com

2. Device Information

Trade nameZirconia Dental Ceramics
Common nameDental Zirconia Ceramics
ClassificationII
Classification namePorcelain powder for clinical use
Product codeEIH
Regulation No.21 CFR 872.6660

3. Legally Marketed Predicate Device

Trade NameDental Zirconia Blocks
510(k) NumberK192262
Product CodeEIH
ManufacturerDe Corematrix Co.Ltd.

4. Legally Marketed Reference Device

Trade NameX-cera Zirconia Blanks
510(k) NumberK153767
Product CodeEIH

{4}------------------------------------------------

Shenzhen XiangTong Photoelectricity Technology Co., Ltd. Manufacturer |

5. Device Description

Zirconia Dental Ceramics is composed of yttria-stabilized zirconia. It contains ZrQz+HfO2+Y2O3 and additional Al2O3 and other oxides. It offers various shapes and dimensions suitable for different milling systems. The performance of the proposed device conforms to ISO 6872:2015 Dentistry: Ceramic Materials.

The proposed device is processed into the dental restorations such as crowns, bridges, veneers, inlays and onlays based on the anatomical rendering of the patient's teeth using CAD/CAM (computer aided design / computer aided manufacturing) method or manual milling method.

The proposed device is a single-use device, and provided non-sterile.

6. Intended Use/Indication for Use

Zirconia Dental Ceramics are intended for dental restorations using different CAD/CAM or manual milling machines. All blocks are processed through dental laboratories or by dental professionals.

7. Substantial Equivalence Comparison

ComparisonitemProposed Device(K214005)Predicate Device(K192262)Reference Device(K153767)Comment
ManufacturerShenzhen YuruchengDental Materials Co., Ltd.De Corematrix Co.Ltd.Shenzhen XiangTongPhotoelectricityTechnology Co., Ltd.None
ProductNameZirconia Dental CeramicsDental Zirconia BlocksX-cera Zirconia BlanksNone
Product CodeEIHEIHEIHSame
RegulationNumber21 CFR § 872.666021 CFR § 872.666021 CFR § 872.6660Same
ClassificationClass IIClass IIClass IISame
PrescriptionUseYesYesYesSame
Indicationsfor UseZirconia Dental Ceramicsare intended for dentalrestorations using differentCAD/CAM or manualmilling machines. Allblocks are processedthrough dental laboratoriesDental Zirconia Blocks areintended for use for theproduction of artificialteeth in fixed or removabledentures, or for jacketcrowns, facing, andveneers. All Blocks areX-cera Zirconia Blanks areindicated for theproduction of artificialteeth in fixed orremovable dentures, or forjacket crowns, facings,and veneers.Similar
or by dental professionals.processed through dentallaboratories or by dentalprofessionals.
Class(per ISO6872:2015)Type II, Class 5Type II, Class 5Type II, Class 6(per ISO 6872:2008)Same
IntendedUserProfessional dentaltechniciansProfessional dentaltechniciansProfessional dentaltechniciansSame
Single UseYesYesYesSame
SterileNon-sterileNon-sterileNon-sterileSame
ShapeCylinder, Cuboid, U-shapeBlocks, DiscCylinder, Disc, BlockSimilar toreferencedevice
DimensionVariousVariousVariousDifferent
ColorWhiteWhite, ColorWhiteSimilar
CompositionZrO2+HfO2+Y2O3: ≥99%Y2O3: 4.5%~6.0%HfO2: ≤5%Al2O3: ≤0.5%Other oxide: ≤0.5%WhiteZrO2+HfO2+Y2O3: ≥99%Y2O3: 4.5%~6.0%HfO2: ≤5%Al2O3: ≤0.5%Other oxide: ≤0.5%ZrO2: 88%~96%Y2O3: 4%~10%Al2O3: <1%HfO2: <0.05%SiO2: <0.5%Same
PhysicalPropertiesConform to ISO6872:2015Conform to ISO6872:2015Conform to ISO6872:2008Same
UniformityUniformUniformUniformSame
FreedomfromextraneousmaterialsFree from extraneousmaterialsFree from extraneousmaterialsFree from extraneousmaterialsSame
Radioactivity≤ 1.0 Bq.g-1≤ 1.0 Bq.g-1≤ 1.0 Bq.g-1Same
Flexuralstrength≥ 800 MPa> 800 MPa≥ 800 MPaSimilar
Chemicalsolubility< 100 µg/cm²< 100 µg/cm²≤ 100 µg/cm²Same
Linearthermalexpansioncoefficient(10.5±0.5)×10-6 K-1Not publicly available(10.5±0.5)×10-6 K-1Different
Shrinkagefactor1.253±0.002Not publicly availableShrinkage: 19%~22%Different
FractureToughness≥ 5.0 MPa*m1/2≥ 5.0 MPa*m1/2≥ 5.0 MPa*m1/2Same

Table 1 Substantial Equivalence Comparison

{5}------------------------------------------------

Version: A/0

{6}------------------------------------------------

Shenzhen Yurucheng Dental Materials Co., Ltd.

Product: Zirconia Dental Ceramics

BiocompatibilityConform to ISO7405:2018, FDA GuidanceConform to ISO10993-1:2018,GuidanceISO FDAConform to ISO 7405 andISO 10993Similar
LabelingComplied with 21 CFRpart 801Complied with 21 CFRpart 801Complied with 21 CFRpart 801Same

The proposed device has the similar indication for use as the predicate device as well as comparable technical and biocompatibility properties and characteristics, and the minor differences don't raise any additional questions for safety and effectiveness, therefore, the proposed device is substantially equivalent to the predicate device.

8. Non-clinical Testing

> Performance Testing

The performance tests were performed according to ISO 6872:2015 Dentistry -Ceramic materials, and the test results showed that the proposed device meets the requirements specified in the standard (see Table 2).

Test ItemTest ResultsJudgment
UniformityUniformPass
Freedom from extraneousmaterialsFree from extraneous materialsPass
Radioactivity<0.017 Bq.g-1Pass
Flexural strength1076.4 MPaPass
Linear thermal expansioncoefficient10.7×10-6K-1Pass
Chemical solubility54.2 µg/cm²Pass
Shrinkage factor1.254Pass
Fracture Toughness16.32 MPa*m1/2Pass

Table 2 Summary of Performance Testing

Biocompatibility Testing A

The biocompatibility tests were performed according to ISO 7405:2018 Dentistry -Evaluation of biocompatibility of medical devices used in dentistry (see Table 3), and the test results showed that the proposed device has no biocompatibility issues.

Biological EndpointReferenceTest Result
CytotoxicityISO 10993-5:2009No cytotoxicity under the conditionsof the study
Table 3 Summary of Biocompatibility Testing
-------------------------------------------------

{7}------------------------------------------------

Version: A/0

6.2 of ISO 7405:2018No cytotoxicity under the conditions of the study
6.3 of ISO 7405:2018No cytotoxicity under the conditions of the study
Skin SensitizationISO 10993-10:2010No skin sensitization under the conditions of the study
Oral Mucosa IrritationISO 10993-10:2010No oral mucosa irritation under the conditions of the study
Acute Systemic ToxicityISO 10993-11:2017No acute systemic toxicity under the conditions of the study
Subchronic Systemic ToxicityISO 10993-11:2017No subchronic systemic toxicity under the conditions of the study
GenotoxicityISO 10993-3:2014No genotoxicity under the conditions of the study
ImplantationISO 10993-6:2016No local effects under the conditions of the study

The results of the non-clinical testing demonstrate that the proposed device is equivalent to the predicate device.

9. Clinical Testing

No clinical study is included in this submission.

10. Conclusions

The results of comparing the design specifications and non-clinical testing between the proposed device and the legally marketed predicate device (K192262) show that they are Substantially Equivalent (SE).

§ 872.6660 Porcelain powder for clinical use.

(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.